VHT vs XLV
YTDYear to date
XLV wins+0.7 pts
Past year
XLV wins+1.6 pts
Fee
XLV winslower fee
Yield
Level
AUM
XLV2.2× more
3–0XLV wins
VHT and XLV · year-to-date · as of Nov 4, 2026 · AUM not scored
XLV vs S&P 500
1M$184.02 · −0.3% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D1M ▼3MYTD1Y3Y5YMAX
Total return−0.3%+9.9%+12.5%+20.4%+29.7%+57.1%+50.7%+685.1%
Peer average+0.6%+4.0%+6.1%+21.0%+29.0%+81.2%+28.9%—
S&P 500 · VOO+0.3%−2.6%−1.7%+11.5%+11.9%+90.9%+77.5%+816.4%
SPDR XLV and Vanguard VOO · total return, dividends in · as of Nov 4, 2026
XLV’s Holdings
TodayLLYEli Lilly +16.5%JNJ9.9%ABBV7.7%UNH5.5%MRK5.4%TMO3.9%AMGN3.7%GILD3.1%ABT2.7%PFE2.6%ISRG2.4%DHR2.2%VRTX2.1%BMY1.9%MDT1.8%CVS1.7%MCK1.7%SYK1.6%ELV1.4%MRNAREGNCI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 1, 2026
All 39 Health Care ETFs
1Y| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +20.4% | +29.7% | $48.5B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.4% | +19.6% | +28.1% | $21.8B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.4% | +27.2% | +38.1% | $10.8B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +16.0% | +24.7% | $4.6B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.5% | −8.9% | −5.8% | $3.7B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.2% | +19.7% | +28.2% | $3.5B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +70.9% | +59.0% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.9% | +42.7% | $1.6B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.7% | +24.0% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +22.5% | new | $1.2B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +33.8% | +46.6% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +21.8% | +24.6% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +17.0% | +30.8% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +24.5% | +34.6% | $579M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +35.0% | +41.8% | $525M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 4, 2026
XLV Payouts by Year
13YLatest payout, Sep 2026
$0.64
a share · every quarter
1.4% yield
1.4% yield
13 years added up
$22.23 a share
$22.23 a share
SPDR XLV · per-share distributions by ex-date · 2014–2026
XLV’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFThis fund | 0.08% | 1.4% | −0.3% | +20.4% | +29.7% | $48.5B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.4% | −0.1% | +19.6% | +28.1% | $21.8B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.4% | +1.9% | +27.2% | +38.1% | $10.8B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | −0.4% | +19.8% | +28.6% | $4.7B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | −0.5% | +16.0% | +24.7% | $4.6B | |
| 6 | IHI | iShares U.S. Medical Devices ETFReadVersus | 0.37% | 0.5% | −0.1% | −8.9% | −5.8% | $3.7B |
#15 of 33 this year · #1 cheapest of 39 · sorted by assetsOpen the Sectors table →
XLV and its peer group · total return · as of Nov 4, 2026
Cards for This View
XLV’s Top 10 Holdings
Today61.0%of XLV sits in these 10
SPDR XLV · weight in the fund · as of Nov 1, 2026
XLV’s Holdings
TodayLLYEli Lilly +16.5%JNJ9.9%ABBV7.7%UNH5.5%MRK5.4%TMO3.9%AMGN3.7%GILD3.1%ABT2.7%PFE2.6%ISRG2.4%DHR2.2%VRTX2.1%BMY1.9%MDT1.8%CVS1.7%MCK1.7%SYK1.6%ELV1.4%MRNAREGNCI39 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
SPDR XLV · 61 holdings · tile size = share of the fund · as of Nov 1, 2026
XLV vs Peer Average
YTDXLVAvsBPeer average
1D−0.3%+0.6%
1M+9.9%+4.0%
3M+12.5%+6.1%
YTD+20.4%+21.0%
1Y+29.7%+29.0%
3Y+57.1%+81.2%
5Y+50.7%+28.9%
4–3XLV wins
38 Health care peers · each row scaled to its leader